Everything tagged "nasdaq" across research, earnings, and macro.
60 articles
Kardigan is expected to list on NASDAQ on 2026-06-18, with shares priced at $14.00 to $16.00. The IPO centers on a clinical-stage cardiovascular pipeline and a balance sheet that still needs capital to keep advancing. Watch whether investors focus on the three lead programs or the company’s going-concern warning.
Honeywell Aerospace Inc. Common Stock When Issued (NASDAQ: HONAV) is expected to list on 2026-06-15, but the price range has not been disclosed. This is a spin-off, not a traditional cash-raising IPO, so the key question is how the market values the standalone aerospace business. The setup favors investors who want a large, profitable aerospace supplier, but they should watch leverage and separation costs closely.
SL Science Holding Limited Ordinary Shares (SLBT) is expected to list on Nasdaq on 2026-06-15, but the price range has not been disclosed. This is a de-SPAC listing rather than a traditional IPO, so the key question is whether the market gives credit to a small-revenue biotech platform with a very large headline valuation.
Honeywell International Inc. Common Stock Ex Distribution When Issued (HONIV) is expected to list on NASDAQ on 2026-06-15, with the price range not disclosed. This is not a traditional IPO; it is a when-issued ex-distribution trading designation tied to Honeywell’s planned spin-off of Solstice Advanced Materials. The setup favors event-driven traders watching the separation mechanics, while the main risk is that this is a corporate action, not a new capital raise.
F/m Accumulator Ultrashort Treasury Fund (SGVA) is expected to list on NASDAQ on 2026-06-11, but the price range has not been disclosed. This is a fund launch, not a traditional operating-company IPO, so the key question is whether its tax-managed ultrashort Treasury strategy can stand out. The setup favors investors who want cash-like exposure with a distribution-minimizing wrapper, while the main watch item is whether the structure can compete with larger Treasury ETF incumbents.
Avalanche Treasury Corporation Class A Common Stock (AVAT) is expected to list on NASDAQ on 2026-06-11, but the price range has not been disclosed. This is not a standard operating-company IPO; it is the public vehicle for a SPAC business combination tied to Avalanche’s digital asset treasury strategy. Bulls will like the AVAX exposure and ecosystem ties, while bears will focus on crypto volatility and deal-execution risk.
Aperture AC Rights (NASDAQ: APURR) is expected to list on 2026-06-10, but the price range has not been disclosed. The deal is a SPAC, so the real story is not current revenue — it is whether the sponsor can find a credible digital-asset target and keep enough cash in the trust to close it.
Einride AB American Depositary Shares are expected to list on NASDAQ on 2026-06-10 under ticker ENRD, but the price range has not been disclosed. The deal is a SPAC business combination with Legato Merger Corp. III, so the key watch item is how the market values a capital-intensive autonomy story with real revenue but heavy execution risk.
Bitzero Holdings Inc. Common Shares (NASDAQ: AIBZ) is expected to list on 2026-06-09, but the price range has not been disclosed. The setup is a classic bull-bear split: renewable-powered data-center growth and AI/HPC exposure on one side, ongoing losses and crypto volatility on the other.
Veraxa Biotech AG Ordinary Shares (NASDAQ: VRXA) is expected to list on 2026-06-10, but the price range has not been disclosed. This is a SPAC business combination rather than a traditional IPO, with the story centered on a pre-commercial oncology pipeline. Bull case: a differentiated antibody-therapy platform; bear case: no product revenue yet and heavy financing needs.
Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) is expected to list on 2026-06-09, but the price range has not been disclosed. The company is a clinical-stage biotech, so the key question is whether investors are willing to fund a thin pipeline and a going-concern story. The setup favors traders watching for financing support and clinical execution, while shareholders should watch dilution risk closely.
Fort Technology Inc. Common Shares (NASDAQ: FRTT) is expected to list on 2026-06-08, but the price range has not been disclosed. The company is a small Amazon-first pest control CPG business with a Europe-heavy footprint and a future U.S. expansion plan. The bull case is marketplace execution; the bear case is dependence on Amazon, thin scale, and ongoing capital needs.
Generate AI research on any ticker — grades, price targets, and full analysis in minutes.
Open the Generator